Orchestra BioMed Holdings (OBIO) Gross Profit (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Gross Profit came in at $78000.0 in Q1 2026, down 90.53% year-on-year from $824000.0 in Q1 2025, and down 99.75% on a QoQ basis from $30.9 million in Q4 2025.
Orchestra BioMed Holdings (OBIO) Gross Profit (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Gross Profit data on file, last reported at $78000.0 in Q1 2026.
- On a quarterly basis, Gross Profit fell 90.53% year-over-year to $78000.0 in Q1 2026; TTM through Mar 2026 was $32.5 million, a 1118.04% increase from a year earlier, with the FY2025 full-year figure at $33.3 million, up 1267.79% from the prior year.
- Gross Profit for Q1 2026 stood at $78000.0, down from $30.9 million in the prior quarter.
- Over the last five years, Gross Profit for OBIO reached as high as $30.9 million in Q4 2025 and fell as low as $78000.0 in Q1 2026.
- Historically, Gross Profit has averaged $2.5 million across 5 years, with a median of $812000.0 in 2025.
- Across the five-year window, Gross Profit jumped 15728.72% in 2025 and slumped 90.53% in 2026, its largest moves.
- Year by year, Gross Profit stood at $1.0 million in 2022, then slumped by 79.52% to $215000.0 in 2023, then slipped by 9.3% to $195000.0 in 2024, then soared by 15728.72% to $30.9 million in 2025, then plunged by 99.75% to $78000.0 in 2026.
- Per Business Quant data, the three most recent Gross Profit figures were $78000.0 in Q1 2026, $30.9 million in Q4 2025, and $812000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78,000.00 |
| Mar 31, 2026 | 78,000.00 |
| Dec 31, 2025 | 30.87 Mn |
| Dec 31, 2025 | 30.87 Mn |
| Sep 30, 2025 | 812,000.00 |
| Sep 30, 2025 | 812,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Mar 31, 2025 | 824,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Sep 30, 2024 | 919,000.00 |
| Sep 30, 2024 | 919,000.00 |
| Jun 30, 2024 | 734,000.00 |
| Jun 30, 2024 | 734,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Mar 31, 2024 | 586,000.00 |
| Dec 31, 2023 | 215,000.00 |
| Dec 31, 2023 | 215,000.00 |